(410 ILCS 455/15)
Parkinson's Disease Public Awareness and Education Program.
(a) Subject to appropriation, the Director shall establish a Parkinson's Disease Public Awareness and Education Program.
(b) The purpose of the Program is to promote public awareness of Parkinson's disease and the value of early detection and possible treatments, including the benefits and risks of those treatments. The Department may accept for that purpose any special grant of moneys, services, or property from the federal government or any of its agencies, or from any foundation, organization, or medical school.
(c) The Program shall include the following:
(1) Development of a public education and outreach
campaign to promote Parkinson's disease awareness and education, including, but not limited to, the following subjects:
(A) the cause and nature of the disease;
(B) diagnostic procedures and appropriate
indications for their use;
(C) lifestyle issues relating to how a person
copes with Parkinson's disease, including, but not limited to, nutrition, diet, and physical exercise;
(D) environmental safety and injury prevention;
(E) availability of Parkinson's disease
diagnostic and treatment services in the community.
(2) Development of educational materials to be made
available to consumers through local physicians, hospitals, clinics, and boards of health.
(3) Development of professional education programs
for health care providers to assist them in understanding research findings and the subjects set forth in paragraph (1) of this subsection.
(4) Development of educational programs for other
personnel, including judicial staff, police officers, fire fighters, and social services and emergency medical service providers, to assist them in recognizing the symptoms of Parkinson's disease and understanding how to respond to the needs of persons with the disease in the course of performing their duties, including dissemination of the informational booklet prepared under Section 20 of this Act.
(5) Development and maintenance of a list of current
providers of specialized services for the diagnosis and treatment of Parkinson's disease. Dissemination of the list shall be accompanied by a description of diagnostic procedures, appropriate indications for their use, and a cautionary statement about the current status of Parkinson's disease research and treatment. The statement shall also indicate that the Department does not endorse specific Parkinson's disease programs or centers in this State.
(Source: P.A. 101-107, eff. 1-1-20